These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 10980615)
1. Functional consequences of tumorigenic missense mutations in the amino-terminal domain of Smad4. Morén A; Itoh S; Moustakas A; Dijke P; Heldin CH Oncogene; 2000 Sep; 19(38):4396-404. PubMed ID: 10980615 [TBL] [Abstract][Full Text] [Related]
2. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction. Kuang C; Chen Y Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410 [TBL] [Abstract][Full Text] [Related]
3. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines. Fink SP; Mikkola D; Willson JK; Markowitz S Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756 [TBL] [Abstract][Full Text] [Related]
4. An extended bipartite nuclear localization signal in Smad4 is required for its nuclear import and transcriptional activity. Xiao Z; Latek R; Lodish HF Oncogene; 2003 Feb; 22(7):1057-69. PubMed ID: 12592392 [TBL] [Abstract][Full Text] [Related]
5. Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta. Chen SJ; Yuan W; Lo S; Trojanowska M; Varga J J Cell Physiol; 2000 Jun; 183(3):381-92. PubMed ID: 10797313 [TBL] [Abstract][Full Text] [Related]
6. Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis. Imai Y; Kurokawa M; Izutsu K; Hangaishi A; Maki K; Ogawa S; Chiba S; Mitani K; Hirai H Oncogene; 2001 Jan; 20(1):88-96. PubMed ID: 11244507 [TBL] [Abstract][Full Text] [Related]
7. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984 [TBL] [Abstract][Full Text] [Related]
8. Cyclic adenosine 3',5'-monophosphate-elevating agents inhibit transforming growth factor-beta-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism. Schiller M; Verrecchia F; Mauviel A Oncogene; 2003 Dec; 22(55):8881-90. PubMed ID: 14654784 [TBL] [Abstract][Full Text] [Related]
12. A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3. Dennler S; Huet S; Gauthier JM Oncogene; 1999 Feb; 18(8):1643-8. PubMed ID: 10102636 [TBL] [Abstract][Full Text] [Related]
13. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses. Levy L; Hill CS Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802 [TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a human smad3 splicing variant lacking part of the linker region. Kjellman C; Honeth G; Järnum S; Lindvall M; Darabi A; Nilsson I; Edvardsen K; Salford LG; Widegren B Gene; 2004 Mar; 327(2):141-52. PubMed ID: 14980711 [TBL] [Abstract][Full Text] [Related]
16. Roles for lysine residues of the MH2 domain of Smad3 in transforming growth factor-beta signaling. Imoto S; Sugiyama K; Sekine Y; Matsuda T FEBS Lett; 2005 May; 579(13):2853-62. PubMed ID: 15907489 [TBL] [Abstract][Full Text] [Related]
17. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells. Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655 [TBL] [Abstract][Full Text] [Related]
18. Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-beta/Smad3-mediated signaling. Goto D; Nakajima H; Mori Y; Kurasawa K; Kitamura N; Iwamoto I Biochem Biophys Res Commun; 2001 Mar; 281(5):1100-5. PubMed ID: 11243848 [TBL] [Abstract][Full Text] [Related]
19. Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner. Verrecchia F; Vindevoghel L; Lechleider RJ; Uitto J; Roberts AB; Mauviel A Oncogene; 2001 Jun; 20(26):3332-40. PubMed ID: 11423983 [TBL] [Abstract][Full Text] [Related]
20. The L3 loop and C-terminal phosphorylation jointly define Smad protein trimerization. Chacko BM; Qin B; Correia JJ; Lam SS; de Caestecker MP; Lin K Nat Struct Biol; 2001 Mar; 8(3):248-53. PubMed ID: 11224571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]